Thomas Friedberg

4.2k total citations
83 papers, 3.5k citations indexed

About

Thomas Friedberg is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas Friedberg has authored 83 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 38 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Thomas Friedberg's work include Pharmacogenetics and Drug Metabolism (61 papers), Drug Transport and Resistance Mechanisms (24 papers) and Glutathione Transferases and Polymorphisms (16 papers). Thomas Friedberg is often cited by papers focused on Pharmacogenetics and Drug Metabolism (61 papers), Drug Transport and Resistance Mechanisms (24 papers) and Glutathione Transferases and Polymorphisms (16 papers). Thomas Friedberg collaborates with scholars based in United Kingdom, Germany and United States. Thomas Friedberg's co-authors include C. Roland Wolf, Franz Oesch, Michael P. Pritchard, Brian Burchell, Hansruedi Glatt, Michael Arand, Denggao Yao, Shaohong Ding, Albrecht Buchmann and Kim Brøsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Thomas Friedberg

83 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Friedberg United Kingdom 35 1.8k 1.5k 961 415 404 83 3.5k
Elizabeth A. Shephard United Kingdom 35 1.5k 0.8× 1.8k 1.2× 825 0.9× 385 0.9× 272 0.7× 116 4.0k
Richard Weaver United Kingdom 36 1.7k 0.9× 1.2k 0.8× 1.2k 1.3× 248 0.6× 284 0.7× 86 3.9k
Donald S. Davies United Kingdom 31 1.3k 0.7× 923 0.6× 709 0.7× 254 0.6× 359 0.9× 92 3.0k
Johannes Doehmer Germany 31 1.2k 0.7× 1.2k 0.8× 465 0.5× 245 0.6× 859 2.1× 106 2.9k
Cosette J. Serabjit‐Singh United States 24 1.2k 0.7× 883 0.6× 1.3k 1.3× 209 0.5× 210 0.5× 40 3.1k
Yune‐Fang Ueng Taiwan 32 1.9k 1.0× 1.4k 0.9× 910 0.9× 236 0.6× 539 1.3× 92 3.7k
Nobumitsu Hanioka Japan 29 1.3k 0.7× 953 0.6× 837 0.9× 224 0.5× 283 0.7× 144 3.3k
Ida S. Owens United States 31 2.1k 1.2× 2.3k 1.5× 1.1k 1.2× 173 0.4× 422 1.0× 65 4.4k
J R Gillette United States 22 3.1k 1.7× 900 0.6× 1.1k 1.2× 349 0.8× 239 0.6× 41 4.3k
Norie Murayama Japan 39 3.1k 1.8× 1.2k 0.8× 1.6k 1.7× 512 1.2× 386 1.0× 235 5.0k

Countries citing papers authored by Thomas Friedberg

Since Specialization
Citations

This map shows the geographic impact of Thomas Friedberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Friedberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Friedberg more than expected).

Fields of papers citing papers by Thomas Friedberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Friedberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Friedberg. The network helps show where Thomas Friedberg may publish in the future.

Co-authorship network of co-authors of Thomas Friedberg

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Friedberg. A scholar is included among the top collaborators of Thomas Friedberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Friedberg. Thomas Friedberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masereeuw, Rosalinde, et al.. (2009). In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part I: beyond the reduction of animal model use. Drug Discovery Today. 14(7-8). 401–405. 10 indexed citations
2.
Weidlich, Simone, et al.. (2004). Proteasomal Degradation of Human CYP1B1: Effect of the Asn453Ser Polymorphism on the Post-Translational Regulation of CYP1B1 Expression. Molecular Pharmacology. 67(2). 435–443. 69 indexed citations
3.
Cummings, Jeffrey L., Noam Zelcer, John Allen, et al.. (2003). Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins. Biochemical Pharmacology. 67(1). 31–39. 56 indexed citations
4.
Rusling, James F., et al.. (2003). An amperometric biosensor with human CYP3A4 as a novel drug screening tool. Biochemical Pharmacology. 65(11). 1817–1826. 122 indexed citations
5.
Breinholt, Vibeke, et al.. (2002). In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food and Chemical Toxicology. 40(5). 609–616. 138 indexed citations
6.
Friedberg, Thomas, Michael P. Pritchard, M. Bandera, et al.. (1999). MERITS AND LIMITATIONS OF RECOMBINANT MODELS FOR THE STUDY OF HUMAN P450-MEDIATED DRUG METABOLISM AND TOXICITY: AN INTRALABORATORY COMPARISON. Drug Metabolism Reviews. 31(2). 523–544. 30 indexed citations
7.
Pritchard, Michael P., et al.. (1999). Competition Between Cytochrome P-450 Isozymes for NADPH-Cytochrome P-450 Oxidoreductase Affects Drug Metabolism. Journal of Pharmacology and Experimental Therapeutics. 289(2). 661–667. 30 indexed citations
8.
Zhang, Yan, et al.. (1999). Effects of Human Cytochrome b5on CYP3A4 Activity and Stabilityin Vivo. Archives of Biochemistry and Biophysics. 366(1). 116–124. 40 indexed citations
9.
Keeney, Diane S., et al.. (1998). A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid. Journal of Biological Chemistry. 273(15). 9279–9284. 52 indexed citations
10.
Friedberg, Thomas. (1998). Molecular Biological Methods for Characterizing Drug-Metabolizing Enzymes in Hepatic and Extrahepatic Tissues. Skin Pharmacology and Physiology. 11(2). 61–69. 15 indexed citations
11.
Ibach, Bernd, Kurt Appel, Peter J. Gebicke‐Haerter, et al.. (1998). Effect of phenytoin on cytochrome P450 2B mRNA expression in primary rat astrocyte cultures. Journal of Neuroscience Research. 54(3). 402–411. 9 indexed citations
12.
Pritchard, Michael P., et al.. (1997). A General Strategy for the Expression of Recombinant Human Cytochrome P450s inEscherichia coliUsing Bacterial Signal Peptides: Expression of CYP3A4, CYP2A6, and CYP2E1. Archives of Biochemistry and Biophysics. 345(2). 342–354. 103 indexed citations
13.
Ding, Shaohong, et al.. (1996). Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli. FEBS Letters. 397(2-3). 210–214. 81 indexed citations
14.
Oesch, Franz, Barbara Oesch‐Bartlomowicz, J. F. Arens, et al.. (1994). Mechanism-based predictions of interactions.. Environmental Health Perspectives. 102(suppl 9). 5–9. 8 indexed citations
15.
Arand, Michael, David F. Grant, Jeffrey K. Beetham, et al.. (1994). Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. FEBS Letters. 338(3). 251–256. 128 indexed citations
16.
Oesch, Franz, Barbara Oesch‐Bartlomowicz, Thomas Friedberg, et al.. (1992). Molecular and cellular basis for adequate metabolic design of genotoxicity studies. Toxicology Letters. 64-65. 643–649. 1 indexed citations
17.
Arand, Michael, Thomas Friedberg, & Franz Oesch. (1992). Colorimetric quantitation of trace amounts of sodium lauryl sulfate in the presence of nucleic acids and proteins. Analytical Biochemistry. 207(1). 73–75. 70 indexed citations
18.
Friedberg, Thomas, et al.. (1989). Perfluorodecanoic acid decreases the enzyme activity and the amount of glutathione S-transferases proteins and mRNAs in vivo. Chemico-Biological Interactions. 70(1-2). 127–143. 16 indexed citations
19.
Doehmer, Johannes, Siddhant Dogra, Thomas Friedberg, et al.. (1989). Introduction of Cytochrome P-450 Genes into V79 Chinese Hamster Cells to Generate New Mutagenicity Test Systems. Archives of toxicology. Supplement. 13. 164–168. 7 indexed citations
20.
Steinberg, Pablo, et al.. (1987). Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver.. Molecular Pharmacology. 32(4). 463–470. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth A. Shephard Breakdown of academic impact, for papers by Richard Weaver Breakdown of academic impact, for papers by Donald S. Davies Breakdown of academic impact, for papers by Johannes Doehmer Breakdown of academic impact, for papers by Cosette J. Serabjit‐Singh Breakdown of academic impact, for papers by Yune‐Fang Ueng Breakdown of academic impact, for papers by Nobumitsu Hanioka Breakdown of academic impact, for papers by Ida S. Owens Breakdown of academic impact, for papers by J R Gillette Breakdown of academic impact, for papers by Norie Murayama
Rankless by CCL
2026